_version_ 1785090713252265984
author Pozzo, Federico
Forestieri, Gabriela
Ianna, Giulia
Vit, Filippo
Tissino, Erika
Bittolo, Tamara
Papotti, Robel
Terzi DI Bergamo, Lodovico
Steffan, Agostino
Laureana, Roberta
Tafuri, Agostino
Chiarenza, Annalisa
DI Raimondo, Francesco
Olivieri, Jacopo
Zaja, Francesco
Laurenti, Luca
Ilaria DEL Principe, Maria
Bomben, Riccardo
Zucchetto, Antonella
Rossi, Davide
Gattei, Valter
author_facet Pozzo, Federico
Forestieri, Gabriela
Ianna, Giulia
Vit, Filippo
Tissino, Erika
Bittolo, Tamara
Papotti, Robel
Terzi DI Bergamo, Lodovico
Steffan, Agostino
Laureana, Roberta
Tafuri, Agostino
Chiarenza, Annalisa
DI Raimondo, Francesco
Olivieri, Jacopo
Zaja, Francesco
Laurenti, Luca
Ilaria DEL Principe, Maria
Bomben, Riccardo
Zucchetto, Antonella
Rossi, Davide
Gattei, Valter
author_sort Pozzo, Federico
collection PubMed
description
format Online
Article
Text
id pubmed-10429438
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104294382023-08-17 P594: THE CXCR4-LOW/CD5-HIGH PROLIFERATIVE FRACTION IS ENRICHED IN BTK MUTATIONS AND ANTICIPATES RELAPSE IN IBRUTINIB-TREATED CLL Pozzo, Federico Forestieri, Gabriela Ianna, Giulia Vit, Filippo Tissino, Erika Bittolo, Tamara Papotti, Robel Terzi DI Bergamo, Lodovico Steffan, Agostino Laureana, Roberta Tafuri, Agostino Chiarenza, Annalisa DI Raimondo, Francesco Olivieri, Jacopo Zaja, Francesco Laurenti, Luca Ilaria DEL Principe, Maria Bomben, Riccardo Zucchetto, Antonella Rossi, Davide Gattei, Valter Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429438/ http://dx.doi.org/10.1097/01.HS9.0000969280.78541.51 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Pozzo, Federico
Forestieri, Gabriela
Ianna, Giulia
Vit, Filippo
Tissino, Erika
Bittolo, Tamara
Papotti, Robel
Terzi DI Bergamo, Lodovico
Steffan, Agostino
Laureana, Roberta
Tafuri, Agostino
Chiarenza, Annalisa
DI Raimondo, Francesco
Olivieri, Jacopo
Zaja, Francesco
Laurenti, Luca
Ilaria DEL Principe, Maria
Bomben, Riccardo
Zucchetto, Antonella
Rossi, Davide
Gattei, Valter
P594: THE CXCR4-LOW/CD5-HIGH PROLIFERATIVE FRACTION IS ENRICHED IN BTK MUTATIONS AND ANTICIPATES RELAPSE IN IBRUTINIB-TREATED CLL
title P594: THE CXCR4-LOW/CD5-HIGH PROLIFERATIVE FRACTION IS ENRICHED IN BTK MUTATIONS AND ANTICIPATES RELAPSE IN IBRUTINIB-TREATED CLL
title_full P594: THE CXCR4-LOW/CD5-HIGH PROLIFERATIVE FRACTION IS ENRICHED IN BTK MUTATIONS AND ANTICIPATES RELAPSE IN IBRUTINIB-TREATED CLL
title_fullStr P594: THE CXCR4-LOW/CD5-HIGH PROLIFERATIVE FRACTION IS ENRICHED IN BTK MUTATIONS AND ANTICIPATES RELAPSE IN IBRUTINIB-TREATED CLL
title_full_unstemmed P594: THE CXCR4-LOW/CD5-HIGH PROLIFERATIVE FRACTION IS ENRICHED IN BTK MUTATIONS AND ANTICIPATES RELAPSE IN IBRUTINIB-TREATED CLL
title_short P594: THE CXCR4-LOW/CD5-HIGH PROLIFERATIVE FRACTION IS ENRICHED IN BTK MUTATIONS AND ANTICIPATES RELAPSE IN IBRUTINIB-TREATED CLL
title_sort p594: the cxcr4-low/cd5-high proliferative fraction is enriched in btk mutations and anticipates relapse in ibrutinib-treated cll
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429438/
http://dx.doi.org/10.1097/01.HS9.0000969280.78541.51
work_keys_str_mv AT pozzofederico p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT forestierigabriela p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT iannagiulia p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT vitfilippo p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT tissinoerika p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT bittolotamara p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT papottirobel p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT terzidibergamolodovico p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT steffanagostino p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT laureanaroberta p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT tafuriagostino p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT chiarenzaannalisa p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT diraimondofrancesco p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT olivierijacopo p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT zajafrancesco p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT laurentiluca p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT ilariadelprincipemaria p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT bombenriccardo p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT zucchettoantonella p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT rossidavide p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll
AT gatteivalter p594thecxcr4lowcd5highproliferativefractionisenrichedinbtkmutationsandanticipatesrelapseinibrutinibtreatedcll